Sustained release of anti-PD-1 peptide for perdurable immunotherapy together with photothermal ablation against primary and distant tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sustained release of anti-PD-1 peptide for perdurable immunotherapy together with photothermal ablation against primary and distant tumors

Published:2018-05 Issue: Volume:278 Page:87-99
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Luo Lihua,Yang Jie,Zhu Chunqi,Jiang Mengshi,Guo Xiaomeng,Li Wei,Yin Xiaoyi,Yin Hang,Qin Bin,Yuan Xiaoling,Li Qingpo,Du Yongzhong,You Jian

Funder

National Nature Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference36 articles.

1. Cancer research: past, present and future;Cao;Nat. Rev. Cancer,2011

2. Cancer immunotherapy: harnessing the immune system to battle cancer;Yang;J. Clin. Invest.,2015

3. The future of immune checkpoint therapy;Sharma;Science,2015

4. Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumors;Lechner;Immunotherapy,2011

5. A STING-activating nanovaccine for cancer immunotherapy;Luo;Nat. Nanotechnol.,2017

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment;Cancer Drug Resistance;2024-09-13

2. Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for Cancer Therapy: Materials and Strategies;Advanced Materials;2024-09-12

3. Stimuli-Responsive Nanomaterials for Tumor Immunotherapy;ACS Biomaterials Science & Engineering;2024-08-22

4. Hyperbaric oxygen enhances tumor penetration and accumulation of engineered bacteria for synergistic photothermal immunotherapy;Nature Communications;2024-06-17

5. Enhancing Effector Jurkat Cell Activity and Increasing Cytotoxicity against A549 Cells Using Nivolumab as an Anti-PD-1 Agent Loaded on Gelatin Nanoparticles;Gels;2024-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3